These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33068645)

  • 1. Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
    Laukkanen JA; Kunutsor SK
    Int J Cardiol; 2021 Feb; 324():13-21. PubMed ID: 33068645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and Propensity-Matched Studies.
    Ahmed A; Varghese KS; Fusco PJ; Mathew DM; Mathew SM; Ahmed S; Rogando DO; Salazar SA; Pandey R; Awad AK; Levy KH; Hernandez M; Calixte R
    Innovations (Phila); 2023; 18(1):29-40. PubMed ID: 36628960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease.
    Bi L; Geng Y; Wang Y; Li S; Sun K; Guo Y; Zhang O; Zhang P
    BMC Cardiovasc Disord; 2024 Jul; 24(1):335. PubMed ID: 38961354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Efficacy of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in the Treatment of Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials.
    Llerena-Velastegui J; Zumbana-Podaneva K; Velastegui-Zurita S; Mejia-Mora M; Perez-Tomassetti J; Cabrera-Cruz A; Haro-Arteaga P; de Jesus ACFS; Coelho PM; Sanahuja-Montiel C
    Cardiol Res; 2024 Jun; 15(3):153-168. PubMed ID: 38994227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: An individual patient data pooled meta-analysis of randomized trials.
    Gaudino M; Audisio K; Hueb WA; Stone GW; Farkouh ME; Di Franco A; Rahouma M; Serruys PW; Bhatt DL; Biondi Zoccai G; Yusuf S; Girardi LN; Fremes SE; Ruel M; Redfors B
    J Thorac Cardiovasc Surg; 2024 Mar; 167(3):1022-1032.e14. PubMed ID: 35821087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial.
    Sanz-Sanchez J; Garcia-Garcia HM; Branca M; Frigoli E; Leonardi S; Gagnor A; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andò G; Repetto A; Limbruno U; Garbo R; Sganzerla P; Russo F; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Santarelli A; Sardella G; Varbella F; Tresoldi S; de Cesare N; Rigattieri S; Zingarelli A; Tosi P; van 't Hof A; Boccuzzi G; Omerovic E; Sabaté M; Heg D; Vranckx P; Valgimigli M
    Eur Heart J Acute Cardiovasc Care; 2023 Nov; 12(11):782-791. PubMed ID: 37812760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of coronary revascularization over medical treatment in chronic coronary syndromes: A systematic review and meta-analysis.
    Panuccio G; Carabetta N; Torella D; De Rosa S
    Hellenic J Cardiol; 2024; 78():60-71. PubMed ID: 37949356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.
    Akl E; Sahami N; Labos C; Genest J; Zgheib A; Piazza N; Jolly S
    J Interv Cardiol; 2024; 2024():8646351. PubMed ID: 38505729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials.
    Galli M; Vescovo GM; Andreotti F; D'Amario D; Leone AM; Benenati S; Vergallo R; Niccoli G; Trani C; Porto I
    Minerva Cardiol Angiol; 2023 Apr; 71(2):221-229. PubMed ID: 33944534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to Consider Coronary Revascularization for Stable Coronary Artery Disease.
    Cheng AM; Doll JA
    Med Clin North Am; 2024 May; 108(3):517-538. PubMed ID: 38548461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Complete Revascularization in the ISCHEMIA Trial.
    Stone GW; Ali ZA; O'Brien SM; Rhodes G; Genereux P; Bangalore S; Mavromatis K; Horst J; Dressler O; Poh KK; Nath RK; Moorthy N; Witkowski A; Dwivedi SK; Bockeria O; Chen J; Smanio PEP; Picard MH; Chaitman BR; Berman DS; Shaw LJ; Boden WE; White HD; Fremes SE; Rosenberg Y; Reynolds HR; Spertus JA; Hochman JS; Maron DJ;
    J Am Coll Cardiol; 2023 Sep; 82(12):1175-1188. PubMed ID: 37462593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete versus partial revascularization for older adults with acute coronary syndrome: a meta-analysis and systematic review of randomized and multivariable adjusted data.
    Carvalho Ferreira AL; Garcez de Carvalho Feitoza LP; Cáceres Lessa AY; Chaves de Oliveira J; Chierici Pereira L; Benitez Gonzalez ME; Coelho Pessoa Lima AE; Ferreira Neves HA; Mota Guida C
    Coron Artery Dis; 2024 Jun; ():. PubMed ID: 38829316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous vs surgical revascularization in left main coronary artery disease: A restricted mean survival time analysis of randomized trials.
    Milioglou I; Gillombardo CB; Li J; Filby SJ; Deo S; Al-Kindi S
    Cardiovasc Revasc Med; 2024 Apr; 61():93-94. PubMed ID: 38065714
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous coronary intervention versus optimal medical therapy for stable coronary artery disease: An umbrella review.
    Soriano-Moreno DR; Fernandez-Guzman D; Tuco KG; Soriano-Moreno AN; Ccami-Bernal F; Coico-Lama AH; Gonzáles-Uribe AG; Taype-Rondan A
    Heliyon; 2024 Mar; 10(5):e27210. PubMed ID: 38486733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of the Core Components of Cardiac Rehabilitation on Mortality and Morbidity: A Systematic Review and Network Meta-Analysis.
    Kabboul NN; Tomlinson G; Francis TA; Grace SL; Chaves G; Rac V; Daou-Kabboul T; Bielecki JM; Alter DA; Krahn M
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30518047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and reporting of composite outcomes are often inadequate in randomized clinical trials on pharmacological interventions for coronary artery disease.
    Mozetic de Barros V; Pacheco RL; Cabrera Martimbianco AL; Mozetic V; Junior SC; Riera R
    J Clin Epidemiol; 2024 Jan; 165():111212. PubMed ID: 37939745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.
    Dahabreh IJ; Robertson SE; Tchetgen EJ; Stuart EA; Hernán MA
    Biometrics; 2019 Jun; 75(2):685-694. PubMed ID: 30488513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' preferences for coronary revascularization: a systematic review.
    Magliano CADS; Monteiro AL; de Oliveira Rebelo AR; de Aguiar Pereira CC
    Patient Prefer Adherence; 2019; 13():29-35. PubMed ID: 30636868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite to Clarity: Shifting From Combined to Individual Endpoints in Meta-Analyses of Cardiovascular Outcome Trials.
    Khan SU
    JACC Adv; 2023 Sep; 2(7):100548. PubMed ID: 38939474
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
    Bainey KR; Alemayehu W; Welsh RC; Kumar A; King SB; Kirtane AJ
    J Am Heart Assoc; 2021 Jan; 10(1):e018104. PubMed ID: 33342230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.